Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.

Mesía R, Garcia-Saenz JA, Lozano A, Pastor M, Grau JJ, Martínez-Trufero J, Lambeaz J, Martínez-Galán J, Mel JR, González B, Vázquez S, Mañós M, Taberna M, Cirauqui B, Del Barco E, Casado E, Rubió-Casadevall J, Rodríguez-Jaráiz A, Cruz JJ, Spanish Head And Neck Cancer Cooperative Group (Study TTCC-2007/02)

Open source

DOI
10.1016/j.ijrobp.2016.11.016
Published
2017 Mar 1
Container
International journal of radiation oncology, biology, physics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ijrobp.2016.11.016,
  title = {Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.},
  author = {Mesía R and Garcia-Saenz JA and Lozano A and Pastor M and Grau JJ and Martínez-Trufero J and Lambeaz J and Martínez-Galán J and Mel JR and González B and Vázquez S and Mañós M and Taberna M and Cirauqui B and Del Barco E and Casado E and Rubió-Casadevall J and Rodríguez-Jaráiz A and Cruz JJ and Spanish Head And Neck Cancer Cooperative Group (Study TTCC-2007/02)},
  year = {2017},
  journal = {International journal of radiation oncology, biology, physics},
  doi = {10.1016/j.ijrobp.2016.11.016},
  url = {https://doi.org/10.1016/j.ijrobp.2016.11.016}
}

RIS

TY  - JOUR
TI  - Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.
AU  - Mesía R
AU  - Garcia-Saenz JA
AU  - Lozano A
AU  - Pastor M
AU  - Grau JJ
AU  - Martínez-Trufero J
AU  - Lambeaz J
AU  - Martínez-Galán J
AU  - Mel JR
AU  - González B
AU  - Vázquez S
AU  - Mañós M
AU  - Taberna M
AU  - Cirauqui B
AU  - Del Barco E
AU  - Casado E
AU  - Rubió-Casadevall J
AU  - Rodríguez-Jaráiz A
AU  - Cruz JJ
AU  - Spanish Head And Neck Cancer Cooperative Group (Study TTCC-2007/02)
PY  - 2017
JO  - International journal of radiation oncology, biology, physics
DO  - 10.1016/j.ijrobp.2016.11.016
UR  - https://doi.org/10.1016/j.ijrobp.2016.11.016
ER  - 

APA

R, M., JA, G., A, L., M, P., JJ, G., J, M., J, L., J, M., JR, M., B, G., S, V., M, M., M, T., B, C., E, D. B., E, C., J, R., A, R., JJ, C., & TTCC-2007/02), S. H. A. N. C. C. G. (. (2017). Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.. International journal of radiation oncology, biology, physics. https://doi.org/10.1016/j.ijrobp.2016.11.016

Source records